Represented DiaCarta, Ltd. in its business combination with HH&L Acquisition Co.

Represented DiaCarta, Ltd., a precision molecular diagnostics company and leading developer of novel oncology and infectious disease tests., in its business combination with HH&L Acquisition Co., a special purpose acquisition company.